Melanoma in Immunosuppressed Patients

Disseminated porokeratosis in immunosuppressed patients.

More than a century ago, two Italian dermatologists independently described a new keratotic disorder [1,2] which was called porokeratosis by Mibelli [1]. After these first descriptions, at least four variants of porokeratosis have been recognized. Clinically all these dermatological disorders are characterized by diffuse annular lesions surrounded by a raised, sharply marginated, keratotic bord...

Fungal Infections in Immunosuppressed Patients

Fungal infections, also called mycoses, are important causes of morbidity and mortality in humans. Some fungal infections are endemic, and these infections are usually caused by fungi that are present in the environment and whose spores enter humans. Other fungal infections are said to be opportunistic because the causative agents cause mild or no disease in healthy individuals but may infect a...

Distinct Innate Immune Gene Expression Profiles in Non-Melanoma Skin Cancer of Immunocompetent and Immunosuppressed Patients

Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most frequent skin cancers in humans. An intact immune system is critical for protection against SCC since organ transplant recipients (OTR) have a 60- to 100-fold higher risk for developing these tumors. The role of the innate immune system in tumor immunosurveillance is unclear. Our aim was to determine the expression of sel...

Infection of immunosuppressed patients.

strongyloides stercoralis in immunosuppressed patients

conclusions clinical features of strongyloidiasis are nonspecific, and a high index of suspicion is necessary for early diagnosis and to improve the poor prognosis of patients with hyperinfection syndrome due to s. stercoralis. results s. stercoralis is an intestinal nematode that can survive in asymptomatic form in its human host for decades after the initial infection. however, this geohelmin...